Stephen Thompson

This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.

The paper identifies and evaluates dibasic piperidines as novel cell wall inhibitors against Mycobacterium tuberculosis, showing activity across multiple media and differential sensitivity in resistant strains.

This study shows that menadione reduces virulence and colonization gene expression in H. pylori and inhibits motility, suggesting potential as a virulence-attenuating agent.